Hatteras Investment Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Hatteras Investment Partners’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,471	Closed	-$305K	–	32
2016 Q4	$305K	Sell	5,471 -5,234	-49%	-$252K	1.78%	25
2016 Q3	$489K	Sell	10,705 -8,990	-46%	-$361K	1.68%	20
2016 Q2	$787K	Sell	19,695 -2,455	-11%	-$89.9K	4.4%	6
2016 Q1	$771K	Sell	22,150 -590	-3%	-$21.7K	2.11%	15
2015 Q4	$977K	Buy	+22,740	New	+$1.14M	1.28%	20

Other funds holding BSTC

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Hatteras Investment Partners's BSTC Position: Q1 2017 in Review

Hatteras Investment Partners sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2017, closing a stake of 5,471 shares — an estimated $305K sold.

Hatteras Investment Partners first reported a position in BSTC in Q4 2015 and held it in 5 quarters. The position peaked at $977K in Q4 2015. 89 funds tracked by Wall St. Rank hold BSTC as of Q1 2017.

Hatteras Investment Partners reported no remaining BioSpecifics Technologies Corp. position as of Q1 2017 after selling out during the quarter.
Hatteras Investment Partners sold 5,471 BioSpecifics Technologies Corp. shares in Q1 2017, an estimated $305K.
Hatteras Investment Partners first reported a position in BioSpecifics Technologies Corp. in Q4 2015 and held it in 5 quarters.
Hatteras Investment Partners's BioSpecifics Technologies Corp. position peaked at $977K in Q4 2015.
89 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2017.

Based on Hatteras Investment Partners's 13F filing for Q1 2017.